Clinical Trials on Multiple Myeloma
Total 12415 results
-
PETHEMA FoundationRecruitingMultiple Myeloma in RelapseSpain
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Australia, Denmark, Sweden, Brazil, China, Spain, Czechia, Turkey, Poland, Netherlands, Argentina, Canada, United Kingdom, Greece, India
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedLeukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Roswell Park Cancer InstituteCelgeneActive, not recruitingPlasma Cell Myeloma | Partial Response of Multiple Myeloma or Plasma Cell LeukemiaUnited States
-
Case Comprehensive Cancer CenterWithdrawnMyeloma | Smoldering Myeloma | Monoclonal GammopathyUnited States
-
National Cancer Institute (NCI)TerminatedMonoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
Rennes University HospitalIntergroupe Francophone du MyelomeTerminatedMonoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaFrance
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina and more
-
University of UtahRecruitingSmoldering Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Hellenic Society of HematologyJanssen PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaGreece
-
National Cancer Institute (NCI)TerminatedMultiple Myeloma | Smoldering Multiple Myeloma | MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
University Hospital, MontpellierPoitiers University HospitalUnknownPatients With Recurrent or Refractory Multiple MyelomaFrance
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedMultiple Myeloma Bone DiseaseUnited Kingdom, United States
-
Medical Research CouncilUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLeukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non-hodgkin's LymphomaChina
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Regeneron PharmaceuticalsNot yet recruitingMonoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)
-
Seoul St. Mary's HospitalActive, not recruitingMyeloma MultipleKorea, Republic of
-
M.D. Anderson Cancer CenterRecruiting
-
LifeTime PharmaceuticalsUnknownMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Oxford University Hospitals NHS TrustAmgenCompletedMyeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)United Kingdom
-
Centro de Atencion e Investigacion MedicaNot yet recruiting
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Nantes University HospitalUnknown
-
University of ArkansasCompletedMULTIPLE MYELOMAUnited States
-
Shanxi Bethune HospitalRecruiting
-
Shahid Beheshti University of Medical SciencesNot yet recruitingMultiple Myeloma, RefractoryIran, Islamic Republic of
-
Shenzhen Geno-Immune Medical InstituteThe Second Affiliated Hospital of Hainan Medical UniversityRecruiting
-
University of PennsylvaniaGenentech, Inc.Recruiting
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
Sheba Medical CenterRecruitingMultiple Myeloma | Relapse Multiple MyelomaIsrael
-
Chunrui LiNanjing IASO Biotherapeutics Co.,LtdRecruitingExtramedullary Multiple MyelomaChina
-
Xinqiao Hospital of ChongqingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingMultiple Myeloma, RefractoryChina
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncRecruiting
-
Turkish Hematology AssociationRecruitingMultiple Myeloma | Relapse Multiple MyelomaTurkey
-
Oslo University HospitalRecruiting
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaboratorsRecruitingMultiple Myeloma in RelapseUnited States
-
AbbVieActive, not recruiting
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedRelapsed/Refractory Multiple MyelomaUnited States, France